The Company had the following reserved shares of common stock for future issuance as of the dates noted (in thousands):


	September 30, 2025		June 30, 2025
2013 Equity Incentive Plan shares available for grant		6,276		10,935
Employee stock options and awards outstanding		9,060		7,566
2014 Employee Stock Purchase Plan		5,418		5,952
Total shares reserved for issuance		20,754		24,453

Share-based compensation expense recognized in the condensed consolidated financial statements by line-item caption is as follows (in thousands):


	Three Months Ended
	September 30, 2025		September 30, 2024
Cost of product revenues	$	752	$	618
Cost of subscription and support revenues		727		689
Research and development		4,447		4,213
Sales and marketing		7,513		6,882
General and administrative		8,341		7,365
Total share-based compensation expense	$	21,780	$	19,767

The following table summarizes stock option activity for the three months ended September 30, 2025 (in thousands, except per share amount and contractual term):


	Number of Shares			Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Options outstanding at June 30, 2025		496		$	6.70		1.16	$	5,580
Granted		—			—
Exercised		(71	)		6.70
Canceled		—			—
Options outstanding at September 30, 2025		425		$	6.70		0.91	$	5,923
Vested and expected to vest at September 30, 2025		425		$	6.70		0.91	$	5,923
Exercisable at September 30, 2025		425		$	6.70		0.91	$	5,923

There were no stock options granted during the three months ended September 30, 2025 and 2024.

Stock awards may be granted under the 2013 Plan on terms approved by the Compensation Committee of the Board. Stock awards generally provide for the issuance of restricted stock units (“RSUs”) including performance-condition or market-condition RSUs which vest over a fixed period of time or based upon the satisfaction of certain performance criteria or market conditions. The Company recognizes compensation expense on the stock awards over the vesting period based on the awards’ fair value as of the date of grant. The Company does not estimate forfeitures, but accounts for them as incurred.

The following table summarizes stock award activity for the three months ended September 30, 2025 (in thousands, except grant date fair value):


	Number of Shares			Weighted- Average Grant Date Fair Value		Aggregate Fair Value
Non-vested stock awards outstanding at June 30, 2025		7,070		$	19.53
Granted		4,129			19.57
Released		(2,520	)		18.85
Canceled		(44	)		19.56
Non-vested stock awards outstanding at September 30, 2025		8,635		$	19.73
Stock awards expected to vest at September 30, 2025		8,635		$	19.73	$	170,378

The RSUs granted under the 2013 Plan vest over a period of time, generally one to three years, and are subject to participant's continued service to the Company.

During the three months ended September 30, 2025, the Company granted 0.8 million stock awards with vesting based on market conditions (“MSU”) to certain of the Company’s employees. The MSUs vest based on the Company’s total shareholder return (“TSR”) relative to the TSR of the Russell 2000 Index (“Index”). The MSU award represents the right to receive a target number of shares of common stock of up to 150% of the original grant. The MSUs vest based on the Company’s TSR relative to the TSR of the Index over performance periods of three years from the grant date, subject to the grantees’ continued service through the certification of performance.

The grant date fair value of each MSU was determined using the Monte Carlo simulation model. The weighted-average grant-date fair value of the TSR MSUs granted during the three months ended September 30, 2025 and 2024 was $22.23 per share and $17.22 per share, respectively. The following assumptions used to determine the grant-date fair values of the MSU during the following periods:


	Three Months Ended
	September 30, 2025			September 30, 2024
Expected term	3.0 years			3.0 years
Risk-free interest rate		3.70	%		3.86	%
Volatility		45	%		48	%
Dividend yield		—	%		—	%

As of September 30, 2025, there was $137.3 million in unrecognized compensation cost related to non-vested stock awards, including performance and market condition awards. This cost is expected to be recognized over a weighted average period of 1.95 years.

There were approximately 0.5 million shares issued under the ESPP during each of the three months ended September 30, 2025 and 2024, respectively. The following assumptions were used to determine the grant-date fair values of the ESPP shares during the following periods:


	Employee Stock Purchase Plan
	Three Months Ended
	September 30, 2025			September 30, 2024
Expected term	0.5 years			0.5 years
Risk-free interest rate		4.12	%		5.04	%
Volatility		50	%		36	%
Dividend yield		—	%		—	%

The weighted-average grant-date fair value of shares under the ESPP during the three months ended September 30, 2025 and 2024 was $5.83 and $3.74 per share, respectively.